15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
9
C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof
Youngene Therapeutics
147
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives
Idorsia Pharmaceuticals
2
Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR.
University of Texas Southwestern Medical Center
36
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
Universita Degli Studi Di Milano
17
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity.
Johnson & Johnson Pharmaceutical
29
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
Gsk
37
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Kochi Medical School
37
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.
Nerviano Medical Sciences
19
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
Bristol Myers Squibb